Peer-reviewed literature on the compounds we carry, plus our quality verification process.
High-Performance Liquid Chromatography verifies each compound's purity to ≥97%. Certificates of Analysis (CoA) are available for every batch.
Every batch testedElectrospray Ionization Mass Spectrometry (ESI-MS) confirms molecular weight and structural identity for each peptide.
Identity verifiedLAL testing ensures endotoxin levels remain below USP thresholds, critical for reliable research outcomes.
USP compliantSikiric P, Seiwerth S, Rucman R, et al. · Current Pharmaceutical Design · 2023
A comprehensive review of BPC-157's cytoprotective effects in the GI tract, including wound healing promotion and angiogenesis across multiple organ systems.
Goldstein AL, Hannappel E, Sosne G, et al. · Expert Opinion on Biological Therapy · 2023
Review of TB-500/Thymosin Beta 4's roles in tissue repair, anti-inflammatory signaling, and cellular migration across wound healing models.
Smits MM, Van Raalte DH. · Drugs · 2024
Evaluation of semaglutide's GLP-1 receptor agonist activity, clinical efficacy data, and pharmacokinetic profile across metabolic endpoints.
Pickart L, Vasquez-Soltero JM, Margolina A. · International Journal of Molecular Sciences · 2023
Analysis of copper tripeptide GHK-Cu's effects on gene expression, tissue remodeling, and antioxidant defense mechanisms.
Khavinson V, Linkova N, Dyatlova A, et al. · Bulletin of Experimental Biology and Medicine · 2022
Investigation of Epitalon's effects on telomerase activity, melatonin synthesis, and its potential role in cellular aging research.
Willard FS, Douros JD, Gabe MB, et al. · Nature · 2024
Structural and pharmacological characterization of tirzepatide's dual incretin receptor agonism and its metabolic effects.
Links open peer-reviewed articles on PubMed (NIH). Prince of Peptides provides research compounds only — we make no therapeutic claims.